Edwards Lifesciences ROE 2010-2025 | EW
Current and historical return on equity (ROE) values for Edwards Lifesciences (EW) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Edwards Lifesciences ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $4.18B | $10.19B | 44.75% |
| 2024-12-31 | $4.18B | $10.06B | 48.60% |
| 2024-09-30 | $4.16B | $9.61B | 53.63% |
| 2024-06-30 | $1.47B | $7.51B | 20.94% |
| 2024-03-31 | $1.41B | $7.19B | 20.89% |
| 2023-12-31 | $1.40B | $6.72B | 21.62% |
| 2023-09-30 | $1.43B | $6.73B | 22.86% |
| 2023-06-30 | $1.39B | $6.45B | 22.66% |
| 2023-03-31 | $1.49B | $6.06B | 24.78% |
| 2022-12-31 | $1.52B | $5.81B | 25.56% |
| 2022-09-30 | $1.46B | $6.22B | 24.48% |
| 2022-06-30 | $1.46B | $5.94B | 25.12% |
| 2022-03-31 | $1.54B | $5.85B | 27.54% |
| 2021-12-31 | $1.50B | $5.84B | 28.40% |
| 2021-09-30 | $1.48B | $5.54B | 29.70% |
| 2021-06-30 | $1.46B | $5.13B | 31.50% |
| 2021-03-31 | $0.85B | $4.66B | 19.70% |
| 2020-12-31 | $0.82B | $4.57B | 19.95% |
| 2020-09-30 | $0.79B | $4.21B | 19.73% |
| 2020-06-30 | $0.74B | $3.84B | 18.95% |
| 2020-03-31 | $1.11B | $3.90B | 28.85% |
| 2019-12-31 | $1.05B | $4.15B | 28.09% |
| 2019-09-30 | $0.77B | $3.82B | 22.27% |
| 2019-06-30 | $0.73B | $3.50B | 21.56% |
| 2019-03-31 | $0.77B | $3.45B | 23.37% |
| 2018-12-31 | $0.72B | $3.14B | 22.40% |
| 2018-09-30 | $0.71B | $3.36B | 22.41% |
| 2018-06-30 | $0.66B | $3.16B | 20.98% |
| 2018-03-31 | $0.56B | $3.25B | 18.20% |
| 2017-12-31 | $0.58B | $2.96B | 19.76% |
| 2017-09-30 | $0.75B | $3.16B | 25.99% |
| 2017-06-30 | $0.72B | $2.94B | 26.05% |
| 2017-03-31 | $0.66B | $2.74B | 24.97% |
| 2016-12-31 | $0.57B | $2.62B | 22.62% |
| 2016-09-30 | $0.55B | $2.69B | 22.16% |
| 2016-06-30 | $0.53B | $2.47B | 21.83% |
| 2016-03-31 | $0.52B | $2.30B | 21.66% |
| 2015-12-31 | $0.50B | $2.50B | 21.00% |
| 2015-09-30 | $0.46B | $2.42B | 20.32% |
| 2015-06-30 | $0.44B | $2.29B | 20.14% |
| 2015-03-31 | $0.87B | $2.21B | 41.80% |
| 2014-12-31 | $0.81B | $2.19B | 43.31% |
| 2014-09-30 | $0.78B | $2.04B | 45.42% |
| 2014-06-30 | $0.76B | $1.92B | 48.68% |
| 2014-03-31 | $0.31B | $1.34B | 20.67% |
| 2013-12-31 | $0.39B | $1.54B | 25.29% |
| 2013-09-30 | $0.40B | $1.44B | 26.48% |
| 2013-06-30 | $0.40B | $1.58B | 25.54% |
| 2013-03-31 | $0.37B | $1.59B | 24.50% |
| 2012-12-31 | $0.29B | $1.48B | 19.93% |
| 2012-09-30 | $0.27B | $1.54B | 18.60% |
| 2012-06-30 | $0.25B | $1.44B | 17.98% |
| 2012-03-31 | $0.24B | $1.39B | 17.41% |
| 2011-12-31 | $0.24B | $1.34B | 17.44% |
| 2011-09-30 | $0.24B | $1.36B | 17.68% |
| 2011-06-30 | $0.24B | $1.39B | 17.79% |
| 2011-03-31 | $0.24B | $1.36B | 18.73% |
| 2010-12-31 | $0.22B | $1.31B | 18.20% |
| 2010-09-30 | $0.20B | $1.23B | 17.33% |
| 2010-06-30 | $0.23B | $1.12B | 20.19% |
| 2010-03-31 | $0.22B | $1.15B | 19.80% |
| 2009-12-31 | $0.23B | $1.16B | 22.03% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.910B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.987B | 81.02 |
| Thermo Fisher Scientific (TMO) | United States | $152.862B | 18.49 |
| Alcon (ALC) | Switzerland | $42.991B | 29.05 |
| IDEXX Laboratories (IDXX) | United States | $41.889B | 48.14 |
| DexCom (DXCM) | United States | $32.949B | 50.93 |
| IQVIA Holdings (IQV) | United States | $27.500B | 15.40 |
| Mettler-Toledo (MTD) | United States | $24.243B | 28.83 |
| STERIS (STE) | Ireland | $21.902B | 24.12 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.211B | 0.00 |
| Waters (WAT) | United States | $16.761B | 23.65 |
| Hologic (HOLX) | United States | $14.193B | 15.42 |
| Sysmex ADR (SSMXY) | Japan | $10.525B | 29.86 |
| Penumbra (PEN) | United States | $8.863B | 69.56 |
| Masimo (MASI) | United States | $8.411B | 31.03 |
| Globus Medical (GMED) | United States | $7.025B | 16.74 |
| Glaukos (GKOS) | United States | $5.527B | 0.00 |
| Teleflex (TFX) | United States | $4.852B | 8.01 |
| Integer Holdings (ITGR) | United States | $3.892B | 20.39 |
| TransMedics (TMDX) | United States | $3.505B | 76.18 |
| PROCEPT BioRobotics (PRCT) | United States | $3.157B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.309B | 13.75 |
| Nihon Kohden (NHNKY) | Japan | $2.170B | 24.88 |
| Elekta AB (EKTAY) | Sweden | $1.887B | 16.97 |
| Veracyte (VCYT) | United States | $1.804B | 25.31 |
| Alphatec Holdings (ATEC) | United States | $1.506B | 0.00 |
| Artivion (AORT) | United States | $1.308B | 122.56 |
| OPKO Health (OPK) | United States | $1.110B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.007B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.974B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.884B | 4.70 |
| IRadimed (IRMD) | United States | $0.714B | 36.25 |
| SiBone (SIBN) | United States | $0.710B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.620B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.547B | 11.77 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.529B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.527B | 8.19 |
| Pacific Biosciences Of California (PACB) | United States | $0.435B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.418B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.394B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.374B | 8.69 |
| AngioDynamics (ANGO) | United States | $0.365B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.360B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.307B | 0.00 |
| NeuroPace (NPCE) | United States | $0.307B | 0.00 |
| RxSight (RXST) | United States | $0.299B | 0.00 |
| Neuronetics (STIM) | United States | $0.257B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.250B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.225B | 13.61 |
| CVRx (CVRX) | United States | $0.216B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.120B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.00 |
| Hyperfine (HYPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.062B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.02 |